Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells.

Area of Science:

• Immunology
• Gastroenterology
• Allergy Research

Background:

• Food allergens induce immediate and late-phase intestinal inflammation.
• Epithelial CD23 mediates allergen-IgE complex uptake in the intestine.
• Hypothesis: Allergen-IgE complexes signal via CD23 to initiate inflammation.

Purpose of the Study:

• To investigate the role of epithelial CD23 in allergen-induced intestinal inflammation.
• To determine if allergen-IgE complexes signal through CD23 to trigger inflammatory mediators.
• To assess the impact of this signaling on immune cell recruitment.

Main Methods:

• Caco-2 intestinal cell monolayers stimulated with IgE-antigen complexes.
• Quantification of IL-8 and CCL20 mRNA and protein.
• Analysis of signaling pathways (ERK, JNK, p38, NF-kappaB) and transcription factors (AP-1).
• CD23 knockdown using shRNA and assessment of dendritic cell migration.

Main Results:

• IgE-antigen complexes upregulated IL-8 and CCL20 in Caco-2 cells.
• Signaling involved ERK and JNK phosphorylation and AP-1 activation.
• CD23 cross-linking mimicked IgE-antigen complex effects; CD23 silencing blocked responses.
• Epithelial cell supernatant induced dendritic cell migration, dependent on CCL20.
• CCL20 is constitutively expressed by intestinal epithelial cells in vivo.

Conclusions:

• Epithelial CD23 signaling by allergen-IgE complexes contributes to late-phase inflammation.
• This pathway releases chemokines (CCL20) that recruit antigen-presenting and effector cells.
• CD23-mediated signaling is a potential therapeutic target in food allergy.